Equity Components [Axis]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Treasury Stock [Member]
AOCI Attributable to Parent [Member]
Range [Axis]
Minimum [Member]
Maximum [Member]
Geographical [Axis]
United States [Member]
Other States [Member]
Product and Service [Axis]
First Defense product line [Member]
Other animal health [Member]
Other Product Services [Member]
Related Party Transaction [Axis]
Investor [Member]
Plan Name [Axis]
Two Thousand Plan [Member]
Award Type [Axis]
Employee Stock Option [Member]
Two Thousand Ten Plan [Member]
Two Thousand Seventeen Plan [Member]
Debt Instrument, Redemption, Period [Axis]
Debt Instrument, Redemption, Period One [Member]
Debt Instrument, Redemption, Period Two [Member]
Debt Instrument, Redemption, Period Three [Member]
Debt Instrument, Redemption, Period Four [Member]
Debt Instrument, Redemption, Period Five [Member]
Geographical [Member]
Major Product Category [Member]
Fair Value, Hierarchy [Axis]
Fair Value, Inputs, Level 1 [Member]
Fair Value, Inputs, Level 2 [Member]
Fair Value, Inputs, Level 3 [Member]
Concentration Risk Benchmark [Axis]
Sales Revenue, Net [Member]
Customer [Axis]
Foreign Customers [Member]
United States Dairy And Beef Industries [Member]
Property, Plant and Equipment, Type [Axis]
Manufacturing Facility [Member]
Building Improvements [Member]
Office Equipment [Member]
Construction in Progress [Member]
Land [Member]
Finite-Lived Intangible Assets by Major Class [Axis]
Developed Technology Rights [Member]
Noncompete Agreements [Member]
Customer Relationships [Member]
Td Bank [Member]
Debt Instrument [Axis]
Loan Four [Member]
Loan Three [Member]
Loan One [Member]
Loan Two [Member]
Loan Five [Member]
Credit Facility [Axis]
Line of Credit [Member]
Derivative Instrument [Axis]
Interest Rate Swap [Member]
Scenario [Axis]
Stock Options Granted [Member]
Equity Option [Member]
Employee [Member]
Sale of Stock [Axis]
Private Placement [Member]
Common Stock Rights Plan [Member]
Business Segments [Axis]
Company A [Member]
Company B [Member]
Company C [Member]
Credit Facilities One [Member]
Financial Instrument [Axis]
Loan One [Member]
Loan Two [Member]
Loan Three [Member]
Loan Four [Member]
Period [Axis]
Third Quarter [Member]
Fourth Quarter [Member]
Document and Entity Information [Abstract]
Entity Registrant Name
Entity Central Index Key
Amendment Flag
Current Fiscal Year End Date
Document Type
Document Period End Date
Document Fiscal Period Focus
Document Fiscal Year Focus
Entity Filer Category
Entity Small Business
Entity Emerging Growth Company
Entity Ex Transition Period
Entity Current Reporting Status
Entity Shell Company
Entity Interactive Data Current
Entity Incorporation State Country Code
Entity File Number
Entity Common Stock, Shares Outstanding
Statement of Financial Position [Abstract]
ASSETS
CURRENT ASSETS:
Cash and cash equivalents
Short-term investments
Trade accounts receivable, net
Inventory
Prepaid expenses and other current assets
Total current assets
PROPERTY, PLANT AND EQUIPMENT, net
INTANGIBLE ASSETS, net
GOODWILL
INTEREST RATE SWAPS
OTHER ASSETS
TOTAL ASSETS
LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES:
Accounts payable and accrued expenses
Current portion of bank debt
Line of credit
Total current liabilities
LONG-TERM LIABILITIES:
Bank debt, net of current portion
Interest rate swaps
Total long-term liabilities
TOTAL LIABILITIES
CONTINGENT LIABILITIES AND COMMITMENTS (See Note 17)
STOCKHOLDERS' EQUITY:
Common stock, $0.10 par value per share, 11,000,000 and 11,000,000 shares authorized, 7,299,009 and 5,662,645 shares issued and 7,209,595 and 5,568,962 shares outstanding, as of June 30, 2019 and December 31, 2018, respectively
Additional paid-in capital
Accumulated deficit
Treasury stock, at cost, 89,414 and 93,683 shares as of June 30, 2019 and December 31, 2018, respectively
Accumulated other comprehensive (loss) income
Total stockholders' equity
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY
Common stock, par value (in dollars per share)
Common stock, shares authorized
Common stock, shares issued
Common stock, shares outstanding
Treasury stock, shares
Income Statement [Abstract]
Product sales
Costs of goods sold
Gross margin
Product development expenses
Sales and marketing expenses
Administrative expenses
Operating activities
NET OPERATING LOSS
Other expenses, net
LOSS BEFORE INCOME TAXES
Income tax expense
NET LOSS
Basic weighted average common shares outstanding
Basic net loss per share
Diluted weighted average common shares outstanding
Diluted net loss per share
Statement of Comprehensive Income [Abstract]
Net loss
Other comprehensive (loss) income:
Interest rate swaps, before taxes
Income tax applicable to interest rate swaps
Other comprehensive (loss) income, net of taxes
Total comprehensive loss
Statement [Table]
Statement [Line Items]
Common Stock
Additional paid-in capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Accumulated Other Comprehensive (Loss) Income
Balance
Balance, Shares
Other comprehensive income (loss), net of taxes
Public offering of common stock, net of $696,566 of offering costs
Public offering of common stock, net of $696,566 of offering costs, Shares
Exercise of stock options
Exercise of stock options, Shares
Stock-based compensation
Balance
Balance, Shares
Statement of Stockholders' Equity [Abstract]
Common stock, public offering costs
Statement of Cash Flows [Abstract]
CASH FLOWS FROM OPERATING ACTIVITIES:
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation
Amortization
Amortization of debt issue costs
Deferred income taxes
Stock-based compensation
Changes in:
Accounts receivable, gross
Accrued interest income
Inventory
Prepaid expenses and other current assets
Other assets
Accounts payable and accrued expenses
Net cash provided by operating activities
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property, plant and equipment
Purchases of investments
Payment of contingent royalties related to 2016 acquisition
Net cash used in investing activities
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from public offering, net
Proceeds from debt issuance
Line of credit repayment
Debt principal repayments
Payments of debt issue costs
Proceeds from exercise of stock options
Net cash provided by financing activities
NET DECREASE IN CASH AND CASH EQUIVALENTS
BEGINNING CASH AND CASH EQUIVALENTS
ENDING CASH AND CASH EQUIVALENTS
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
CASH PAID FOR:
Income taxes
Interest expense
NON-CASH ACTIVITIES:
Change in capital expenditures included in accounts payable and accrued expenses
Net change in fair value of interest rate swaps, net of taxes
Fixed asset disposals, gross
Organization, Consolidation and Presentation of Financial Statements [Abstract]
BUSINESS OPERATIONS
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Cash and Cash Equivalents [Abstract]
CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS
Receivables [Abstract]
TRADE ACCOUNTS RECEIVABLE, net
Inventory Disclosure [Abstract]
INVENTORY
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
PREPAID EXPENSES AND OTHER CURRENT ASSETS
Property, Plant and Equipment [Abstract]
PROPERTY, PLANT AND EQUIPMENT, net
Business Combinations [Abstract]
BUSINESS ACQUISITION
Goodwill and Intangible Assets Disclosure [Abstract]
INTANGIBLE ASSETS
Payables and Accruals [Abstract]
ACCOUNTS PAYABLE AND ACCRUED EXPENSES
Debt Disclosure [Abstract]
BANK DEBT
Equity [Abstract]
STOCKHOLDERS' EQUITY
Revenue from Contract with Customer [Abstract]
REVENUE
Gain on Sale of Assets [Abstract]
GAIN ON SALE OF ASSETS
Other Income and Expenses [Abstract]
OTHER EXPENSES, NET
Income Tax Disclosure [Abstract]
INCOME TAXES
Commitments and Contingencies Disclosure [Abstract]
CONTINGENT LIABILITIES AND COMMITMENTS
Segment Reporting [Abstract]
SEGMENT INFORMATION
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS
Retirement Benefits [Abstract]
EMPLOYEE BENEFITS
Subsequent Events [Abstract]
SUBSEQUENT EVENTS
Basis of Presentation
Cash, Cash Equivalents and Short-Term Investments
Accounts Receivable
Inventory
Property, Plant and Equipment
Intangible Assets and Goodwill
Fair Value Measurements
Valuation of Long-Lived Assets
Concentration of Risk
Interest Rate Swap Agreements
Revenue Recognition
Expense Recognition
Income Taxes
Stock-Based Compensation
Net Loss Per Common Share
Use of Estimates
New Accounting Pronouncements
Schedule of financial assets measured at fair value on nonrecurring basis
Schedule of sales to significant customers
Schedule of accounts receivable due from significant customers
Schedule of cash, cash equivalents and short-term investments
Schedule of inventory
Schedule of prepaid expenses and other current assets
Schedule of property, plant and equipment
Schedule of intangible amortization expense
Schedule of intangible assets
Schedule of accounts payable and accrued expenses
Schedule of interest rate swaps classified as level 2 fair value
Schedule of debt proceeds received and principal repayments made during the year
Schedule of principal payments due under debt outstanding
Schedule of activity under the stock option plans
Schedule of additional information about the stock option plans
Schedule of fair value stock option grant using black-scholes option valuation model with the weighted-average assumptions
Disaggregation of Revenue [Table]
Disaggregation of Revenue [Line Items]
Geographic Area [Member]
Schedule of revenue disaggregated by geographic area and major product category
Schedule of other expenses, net
Fair Value, Recurring and Nonrecurring [Table]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value Hierarchy and NAV [Axis]
Assets:
Cash and money market accounts
Bank certificates of deposit
Interest rate swaps
Liabilities:
Interest rate swaps
Schedule of Revenue by Major Customers, by Reporting Segments [Table]
Revenue, Major Customer [Line Items]
Segments [Axis]
Concentration risk percentage
Accounts receivable due from significant customers
Summary of Significant Accounting Policies (Textual)
Federal deposit insurance corporation limits
Property, plant and equipment, description
Concentration risk percentage, description
U.S. government aggregated in excess of FDIC limits
Decrease to income before income taxes, description
Reclassification of current deferred tax liabilities
Advertising expenses
Stock-based compensation
Non-cash income tax expense to create a full valuation allowance against our net deferred tax assets
Outstanding stock options not included in the calculation because the effect would be anti-dilutive
Weighted average number of shares outstanding
Total
Cash and Cash Equivalents and Short-Term Investments (Textual)
Debt covenant, description
Schedule of accounts receivable
Trade accounts receivable, net
Schedule of inventory
Raw materials
Work-in-process
Finished goods
Total
Prepaid expenses
Other receivables
Total
Due from a third party
Property, Plant and Equipment [Table]
Property, Plant and Equipment [Line Items]
Buildings and improvements [Member]
Laboratory and manufacturing equipment [Member]
Office furniture and equipment [Member]
Construction in progress [Member]
Statistical Measurement [Axis]
Property, plant and equipment, gross
Accumulated depreciation
Property, plant and equipment, net
Property, plant and equipment, Estimated Useful Lives
Property, Plant and Equipment (Textual)
Property, plant and equipment, disposals
Depreciation expense
Business Acquisition (Textual)
Total purchase price
Amount paid on acquisition
Technology transfer payment
Aggregate royalties payment
Estimated fair values of accounts payable and accrued expenses
Royalty expense
Estimated fair values of inventory
Estimated fair values of machinery and equipment
Estimated fair values of intangible assets
Estimated fair values of goodwill
Summary of intangible amortization expense
Six-month period ending December 31, 2019
Year ending December 31, 2020
Year ending December 31, 2021
Year ending December 31, 2022
Year ending December 31, 2023
After December 31, 2023
Total
Schedule of Finite-Lived Intangible Assets [Table]
Finite-Lived Intangible Assets [Line Items]
Developed technology [Member]
Customer relationships [Member]
Non-compete agreements [Member]
Gross Carrying Value
Accumulated Amortization
Net Book Value
Intangible Assets (Textual)
Intangible amortization expense
Intangible asset amortized, useful lives
Net value
Accounts payable - trade
Accounts payable - capital
Accrued payroll
Accrued professional fees
Accrued other
Total
(Receipts) payments required by interest rate swaps
Other comprehensive (loss) income, net of taxes
Schedule of Long-term Debt Instruments [Table]
Debt Instrument [Line Items]
Loan #1 [Member]
Loan #2 [Member]
Loan #3 [Member]
Loan #4 [Member]
Loan #5 [Member]
Proceeds from Debt Issue
Debt Principal Repayments
Six-Months ending 12/31/2019
Year ending 12/31/2020
Year ending 12/31/2021
Year ending 12/31/2022
Year ending 12/31/2023
After 12/31/2023
Subtotal
Debt Issuance Costs
Total
Schedule of Short-term Debt [Table]
Short-term Debt [Line Items]
Line of Credit [Member]
Loan 1 and Loan 2 [Member]
Loan 1 and Loan 2 [Member]
Loan 3 and Loan 4 and Loan 5 [Member]
Loan 3 and Loan 4 and Loan 5 [Member]
Bank Debt (Textual)
Number of credit facilities
Maximum limit on issuance of loan, description
Maximum limit on issuance of loan, rate
Proceeds from issuance of loan
Interest payments, term
Loan amortization, term
Balloon principal payment
Balloon principal payment due, description
Outstanding amount of loan
Credit facility aggregate value
Variable interest rate with LIBOR, description
Loan conversion, term
Loan amount available to withdrawn
Warehouse and storage facility
Variable interest rate
Original notional amount
Debt issue costs
Unrestricted cash, cash equivalents and short-term investments
Outstanding under line of credit
Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
2000 Plan [Member]
2010 Plan [Member]
2017 Plan [Member]
Stock Option [Member]
Outstanding, Beginning balance
Grants
Terminations
Exercises
Outstanding, Ending balance
Vested
Vested and expected to vest
Reserved for future grants
Weighted Average Exercise Price, Outstanding, Beginning
Weighted Average Exercise Price, Grants
Weighted Average Exercise Price, Terminations
Weighted Average Exercise Price, Exercises
Weighted Average Exercise Price, Outstanding, Ending
Weighted Average Exercise Price, Vested
Weighted average exercise price, Vested and expected to vest
Aggregate Intrinsic Value, Outstanding, Beginning
Aggregate Intrinsic Value, Outstanding, Ending
Aggregate Intrinsic Value, Vested
Aggregate Intrinsic Value, Vested and expected to vest
Stock option plans [Member]
Number of Shares, Non-vested stock options as of January 1, 2019
Non-vested stock options as of June 30, 2019
Number of Shares, Stock options granted during the six-month period ended June 30, 2019
Number of Shares, Stock options that vested during the six-month period ended June 30, 2019
Number of Shares, Stock options that were forfeited during the six-month period ended June 30, 2019
Weighted Average Fair Value at Grant Date, Non-vested stock options as of January 1, 2019
Weighted Average Fair Value at Grant Date, Non-vested stock options as of June 30, 2019
Weighted Average Fair Value at Grant Date, Stock options granted during the six-month period ended June 30, 2019
Weighted Average Fair Value at Grant Date, Stock options that vested during the six-month period ended June 30, 2019
Weighted Average Fair Value at Grant Date, Stock options that were forfeited during the six-month period ended June 30, 2019
Weighted Average Exercise Price, Non-vested stock options as of January 1, 2019
Weighted Average Exercise Price, Non-vested stock options as of June 30, 2019
Weighted Average Exercise Price, Stock options granted during the six-month period ended June 30, 2019
Weighted Average Exercise Price, Stock options that vested during the six-month period ended June 30, 2019
Weighted Average Exercise Price, Stock options that were forfeited during the six-month period ended June 30, 2019
Risk-free interest rate
Dividend yield
Expected volatility
Expected life
Subsequent Event Type [Axis]
Stockholders' Equity (Textual)
Potential issuance or sale of equity
Gross proceeds
Net proceeds
Common stock shares sold
Number of related investors
Common stock shares issued
Sale of stock, per share
Closing share price
Common stock shares authorized after amendment
Stock option and incentive plan, description
Common stock reserved for issuance under the plan
Weighted average remaining life of options outstanding
Stock option expiration period
Number of stock options exercised
Number of directors exercised stock options
Aggregate intrinsic value of options exercised
Stock option granted during the period
Weighted-average grant date fair values of options granted
Weighted average remaining life of options exercisable
Total unrecognized stock-based compensation related to non-vested stock options
Outstanding non-vested stock options cost expected to be recognized
Number of director exercised stock options
Share-based payment, description
Exercise prices of options outstanding
Common stock purchase price
Employee stock, plan description
Sale of common stock, description
Outstanding rights price per share
Ownership percentage
Option expiry date
Weighted average remaining life of unrecognized stock-based compensation related to non-vested
Potential issuance cost in equity securities
Registration statement, description
Exercise prices
Other [Member]
Total product sales
Other [Member]
Revenue (Textual)
Revenue, description
Received orders from backlogs
Orders received from customers
Orders cleared from customers
Payment [Axis]
Gain on Sale of Assets (Textual)
Sale of technology
Upfront payment received
Second payment due
Third payment due
Interest expense
Interest income
Other gains
Other expenses, net
Operating Loss Carryforwards [Table]
Operating Loss Carryforwards [Line Items]
Income Taxes (Textual)
Income tax expense (benefit)
(Loss) income before income taxes, rate
Tax credit carryforward, description
State tax credit carryforwards
U.S. federal corporate tax rate
Income tax expense in continuing operations increase in the deferred tax assets
Contingent Liabilities and Commitments (Textual)
Termination fee
Purchase of inventory
Other obligations
Milestone payment
Capital expenditures committed
Construction cost payable
Royalty, percentage
Growth assumption, percentage
Royalties due for 2017
Royalties due for 2018
Royalties due for 2019
Royalties due for 2020
Royalties due for 2021 (and thereafter)
Royalties
U.S. dairy and beef industries [Member]
International dairy and beef [Member]
Segment Information (Textual)
Number of business segment
Related Party Transactions (Textual)
Revenues from transactions with related party
Marketing-related payments
Accounts receivable, related parties
Employee Benefits (Textual)
Employee savings plan, description
Defined benefit plans general information, description
Defined benefit plan benefits paid
The percentage amounts represents to accounts receivable due from significant customers as of the balance sheet date.
Capital expenditures committed.
The amount of change in capital expenditures included in accounts payable and accrued expenses.
Common Stock Rights Plan [Member].
Common stock shares authorized after amendment.
It represents about maximum limit on issuance of debt.
It represents about the percentage of maximum limit on issuance of debt.
Represents payment required by the interest rate swap during the period.
Employee.
Description of employee completing service under saving plan.
Weighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans.
Entire disclosure of accounting policy for expense recognition.
Expected dividends to be paid to holders of the underlying shares or financial instruments (expressed as a percentage of the share or instrument's price).
Period the instrument, asset or liability is expected to be outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
Measure of dispersion, in percentage terms (for instance, the standard deviation or variance), for a given stock price.
Risk-free interest rate assumption used in valuing an instrument.
The disclosure of gain on sale of assets.
The entire disclosure of gain on sale of assets.
Growth assumption percentage.
This amount represents income tax applicable to interest rate swap.
Disclosure of accounting policy for determining the interest rate swap agreement.
Comprehensive income, before taxes, from forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.
Production of inventory.
Milestone payment.
The net proceeds incurred from issuance of common stock.
Non cash Fixed asset disposals, gross.
Number of director exercised stock options.
Number of employee exercised stock options.
Represents the number of investors.
OfferingCost
Other obligations.
Continent of Other States.
Percentage of royalty.
Potential issuance of equity securities.
The entire disclosure of prepaid expenses and other Current assets.
Amount of order received from backlogs for the period.
Description of registration statement.
Sale of technology.
Tabular disclosure of accounts receivable due from significant customers that amounted to 10% or more of total trade accounts receivable as of the balance sheet date.
Schedule of interest rate swaps [Table Text Block].
Tabular disclosure of sales to significant customers that amounted to 10% or more of total product sales by the entity during the period.
Amount of second payment due for the period.
Share based compensation arrangement by share based payment award options exercisable weighted average vested.
Share based payment award options exercises in period gross.
Share ased compensation arrangement by share based payment award options vested and expected to vest.
Amount by which current fair value of underlying stock exceeds exercise price of fully vested options outstanding.
It represents share based compensation decrease(increase) in Income(loss) before income tax description.
Weighted average price at which grantees can acquire the shares reserved for issuance under the non vested stock option plan.
Weighted average price at which option holders acquired shares when vesting their stock options.
Stock options granted.
Amount of third payment due for the period.
Two thousand plan.
Two thousand seventeen plan.
Two thousand ten plan.
United states dairy and beef industries.
Continent of United States.
Amount of cash and cash equivalents unrestricted.
Upfront payment received.
Disclosure of accounting policy for valuation of long-lived assets.
Orders received from customers.
Orders cleared from customers.
Major Product Category [Member] [Default Label]
Mwi Animal Health [Member]
Assets, Current
Assets
Liabilities, Current
Liabilities, Noncurrent
Liabilities
Treasury Stock, Value
Stockholders' Equity Attributable to Parent
Liabilities and Equity
Gross Profit
Operating Expenses
Operating Income (Loss)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest
Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Shares, Outstanding
Share-based Payment Arrangement, Noncash Expense
Increase (Decrease) in Accounts and Other Receivables
Increase (Decrease) in Accrued Interest Receivable, Net
Increase (Decrease) in Inventories
Increase (Decrease) in Prepaid Expense and Other Assets
Increase (Decrease) in Other Current Assets
Increase (Decrease) in Accounts Payable and Accrued Liabilities
Net Cash Provided by (Used in) Operating Activities
Payments to Acquire Property, Plant, and Equipment
Payments to Acquire Short-term Investments
Payment for Contingent Consideration Liability, Investing Activities
Net Cash Provided by (Used in) Investing Activities
Repayments of Lines of Credit
Repayments of Debt
Net Cash Provided by (Used in) Financing Activities
Cash and Cash Equivalents, Period Increase (Decrease)
Property, Plant and Equipment Disclosure [Text Block]
Inventory, Policy [Policy Text Block]
Other Assets, Fair Value Disclosure
Other Liabilities, Fair Value Disclosure
Share-based Payment Arrangement, Expense
Accounts Receivable, after Allowance for Credit Loss
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment
Long-term Debt, Current Maturities
Debt Issuance Costs, Net
Long-term Debt
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares
Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price
Sharebased Compensation Arrangement Sharebased Payment Award Option Nonvested Weighted Average Exercise Price
Interest Expense, Other
Interest Income, Other
Other Nonoperating Gains (Losses)